Interv Akut Kardiol. 2020;19(1):68-71 | DOI: 10.36290/kar.2020.021

Transcarotid TAVR: a safe alternative for patients with other vascular access

Pavel Červinka1,2, Radim Špaček1, Petr Vojtíšek3, Robert Bartoš4
1 Klinika kardiologie, Krajská zdravotní, a. s., Masarykova nemocnice v Ústí nad Labem, o. z.
2 UJEP Ústí nad Labem
3 Klinika perioperační a intenzivní medicíny, Krajská zdravotní, a. s., Masarykova nemocnice v Ústí nad Labem
4 Klinika neurochirurgie, Krajská zdravotní, a. s., Masarykova nemocnice v Ústí nad Labem

The authors present a case report of transcarotid TAVR in female patient with no possibility to perform a procedure via other vascular access.

Keywords: TAVR, alternative vascular access, transcarotid TAVR.

Published: June 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Červinka P, Špaček R, Vojtíšek P, Bartoš R. Transcarotid TAVR: a safe alternative for patients with other vascular access. Interv Akut Kardiol. 2020;19(1):68-71. doi: 10.36290/kar.2020.021.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol. 2011;9:15-29. Go to original source... Go to PubMed...
    2. Leon MB, Smith CR, Mack MJ, et al. PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016; 374: 1609-1620. Go to original source...
    3. Reardon MJ, Van Mieghem NM, Popma JJ, et al. SURTAVI Investigators. Surgical or ranscatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017; 376: 1321-1331. Go to original source...
    4. Patel JS, Krishnaswamy A, Svensson LG, et al. Access options for transcatheter aortic valve replacement in patients with unfavorable aortoiliofemoral anatomy. Curr Cardiol Rep. 2016; 18: 110. Go to original source... Go to PubMed...
    5. Henn MC, Percival T, Zajarias A, et al. Learning Alternative access approaches for tanscatheter aortic valve replacement: implications for new transcatheter aortic valve replacement centers. AnnThorac Surg. 2017; 103: 1399-1405. Go to original source...
    6. Mylotte D, Sudre A, Teiger E, et al. Transcarotid transcatheter aortic valve replacement: feasibility and safety. JACC Cardiovasc Interv. 2016; 9: 472-480. Go to original source... Go to PubMed...
    7. Overtchouk P, Alqdeimat I, Coisne A, et al. Transcarotid approach for TAVI: an optimal alternative to the transfemoral gold standard. Ann Cardiothorac Surg 2017; 6(5): 555-557. Go to original source... Go to PubMed...
    8. Modine T, Lemesle G, Azzaoui R, Sudre A. Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: first case report. J Thorac Cardiovasc Surg. 2010; 140: 928-929. Go to original source...
    9. Debry N, Delhaye C, Azmoun A, et al. Transcarotid transcatheter aortic valve replacement: general or local anesthesia. JACC Cardiovasc Interv. 2016; 9: 2113-2120. Go to original source... Go to PubMed...
    10. Kirker EB, Hodson RW, Spinelli KJ, Korngold EC, et al. The carotid artery as a preferred alternative access route for transcatheter aortic valve replacement. Ann Thorac Surg. 2017; 104: 621-629. Go to original source...
    11. Chamandi Ch, Abi-Akar B, Rodés-Cabau J, et al. Transcarotid Compared With Other Alternative Access Route for Transcatheter Aortic Valve replacement. Circ Cardiovasc Interv. 2018; 11: 2-9. Go to original source...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.